- Home
- TRS vs AVBP Comparison
TRS vs AVBP Comparison
Compare TRS & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- AVBP
- Stock Information
- Founded
- TRS 1986
- AVBP 2021
- Country
- TRS United States
- AVBP United States
- Employees
- TRS N/A
- AVBP N/A
- Industry
- TRS Industrial Specialties
- AVBP
- Sector
- TRS Industrials
- AVBP
- Exchange
- TRS Nasdaq
- AVBP NYSE
- Market Cap
- TRS 1.0B
- AVBP 862.8M
- IPO Year
- TRS 2007
- AVBP 2024
- Fundamental
- Price
- TRS $28.38
- AVBP $22.78
- Analyst Decision
- TRS Strong Buy
- AVBP Strong Buy
- Analyst Count
- TRS 1
- AVBP 8
- Target Price
- TRS $40.00
- AVBP $39.00
- AVG Volume (30 Days)
- TRS 438.3K
- AVBP 493.8K
- Earning Date
- TRS 07-29-2025
- AVBP 08-13-2025
- Dividend Yield
- TRS 0.60%
- AVBP N/A
- EPS Growth
- TRS N/A
- AVBP N/A
- EPS
- TRS 0.77
- AVBP N/A
- Revenue
- TRS $939,580,000.00
- AVBP N/A
- Revenue This Year
- TRS $6.37
- AVBP $66.25
- Revenue Next Year
- TRS $5.49
- AVBP N/A
- P/E Ratio
- TRS $35.34
- AVBP N/A
- Revenue Growth
- TRS 3.80
- AVBP N/A
- 52 Week Low
- TRS $19.33
- AVBP $15.47
- 52 Week High
- TRS $28.77
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- TRS 68.18
- AVBP 50.46
- Support Level
- TRS $27.53
- AVBP $22.04
- Resistance Level
- TRS $28.07
- AVBP $25.73
- Average True Range (ATR)
- TRS 0.73
- AVBP 1.40
- MACD
- TRS 0.03
- AVBP -0.25
- Stochastic Oscillator
- TRS 86.32
- AVBP 20.48
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.